RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers.

导出 OA

翻译打印收藏纠错

第一作者： Wendell D,Jones

第一单位： Bioinformatics Group, Q2 Solutions - EA Genomics, 5927 S Miami Blvd, Morrisville, NC 27560, USA.

作者： Wendell D,Jones ^[1] ; Chad M,Michener ^[2] ; Charles,Biscotti ^[3] ; Iona,Braicu ^[4] ; Jalid,Sehouli ^[4] ; Mahrukh K,Ganapathi ^[5] ; Ram N,Ganapathi ^[5]

作者单位： Bioinformatics Group, Q2 Solutions - EA Genomics, 5927 S Miami Blvd, Morrisville, NC 27560, USA. ^[1] Division of Gynecologic Oncology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. ^[2] Department of Anatomic Pathology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. ^[3] Department of Gynecology, Charité Medical University of Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. ^[4] Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas Medical Center, 1021 Morehead Medical Drive, Charlotte, NC 28204, USA. ^[5]

关键词 RNA immune signature high-grade serous ovarian cancer multivariable Cox models survival outcome tumor microenvironment

DOI 10.3390/cancers12030620

PMID 32156016

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交